Fresh analysis indicates that individuals who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds far faster than those who end traditional diet and exercise programs.
Findings released in a leading health publication demonstrates that while obese individuals can lose substantial amounts of their total mass while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"People buying such treatments need to be informed of the risk of fast rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.
That rate of regain implies a return to original weight in about one and a half years.
Analyzing Therapies
The study, which reviewed 37 of trials involving over 9,000 of patients, compared the effects of these new drugs with conventional dieting.
The team emphasize that individuals who shed pounds through diet and exercise typically have a less rapid creep back—perhaps 100 grams monthly—post-intervention.
The Reason for the Quick Regain
Nutrition scientists believe the mode of action of the injections accounts for the heightened weight return.
These medications copy a natural hormone called GLP-1, which moderates hunger.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the system to produce less of its endogenous GLP-1, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this hormone supplement leads to appetite is no longer kept in check, making binge eating much more probable."
A Chronic Disease?
Health authorities suggest the jabs for people with obesity-related health risks, alongside recommended diet and exercise modifications.
Professionals say that, considering the high risk of relapse, the treatment is often ongoing.
This opinion is supported by pharmaceutical companies, who state that the findings "highlight the chronic character of obesity," comparing it to managing conditions like hypertension.
User Testimonies
Users who have stopped the jabs report a intense resurgence of cravings.
"I experienced something flipping and you're instantly ravenous," said a patient.
This challenge is worsened if individuals have not adopted permanent lifestyle or habit modifications during treatment.
Growing Adoption
Figures suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is higher among women than males.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than the NHS.
Ultimately, clinicians stress that while these medications are potent agents for shedding pounds, they are not a permanent cure and long-term success likely depends on combined lifestyle management.
